WASHINGTON, Nov. 2 -- National Institutes of Health has issued a notice called: Prospective Grant of Exclusive Patent License: Catheter-Based Intramyocardial Ablation for Treating Ventricular Arrhythmia in a Human.
The notice was published in the Federal Register on Nov. 2 by Michael Shmilovich, Acting Director, National Heart, Lung, and Blood Institute, Office of Technology Transfer and Development, National Institutes of Health.
Summary: The National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to AntaraCore, Systems, Inc, located in Dover, Delaware, to practice the inventions embodied in the patent applications ...